Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income.
Johnson & Johnson operates as a global healthcare leader, focusing primarily on pharmaceuticals and medical devices. Its operations are divided into two main segments: Innovative Medicine, which develops and markets prescription drugs, and MedTech, which produces medical devices.
Up until 2023, Johnson & Johnson also managed a thriving consumer health division known for well-known products like Tylenol and Band-Aid. That segment was later separated into a standalone company called Kenvue.
With a history spanning more than a century, Johnson & Johnson has built a reputation for continuous innovation and resilience. It has managed to stay competitive through changing markets, patent expirations, economic downturns, and even global health crises.
Financially, Johnson & Johnson continues to generate substantial cash flows that support both reinvestment and shareholder returns. In 2024 alone, it allocated $17 billion toward research and development while distributing $118 billion in dividends, underscoring its strength as a reliable dividend-paying stock. The company has been growing its dividends for 63 consecutive years and currently offers a quarterly dividend of $1.30 per share. The stock has a dividend yield of 2.72%, as of October 13.
READ NEXT: 12 Best Dividend Stocks With Yields Above 4% and Top 15 Dividend Growth Stocks for Long-Term Investors.
